Turn Therapeutics TTRX
NASDAQ TTRX
$10.58 +0.11 (+1.05%)
As of: Oct 21, 2026 · 12:49 PM EDT

Turn Therapeutics (TTRX) Non-Current Assets (2024 - 2026)

Updated

Turn Therapeutics' Non-Current Assets came in at $6.53 million for Q2 2026, down 9.2% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Turn Therapeutics' Non-Current Assets was $6.97 million, up 632.5% from FY2024.

  • Going back by year, Non-Current Assets was $950,965 in FY2024.
  • The five-year range for quarterly Non-Current Assets is $950,965 (Q4 2024) to $7.19 million (Q1 2026).
  • Business Quant data shows TTRX's Non-Current Assets at $7.19 million (Q1 2026), $6.97 million (Q4 2025) and $1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn 141.29 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn 101.45 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn 87.87 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn 35.42 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 159.77 Bn
10 Turn Therapeutics 315.16 Mn 288.27 Mn - 6.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.53 Mn
Mar 31, 2026 7.19 Mn
Dec 31, 2025 6.97 Mn
Sep 30, 2025 1.00 Mn
Dec 31, 2024 950,965.00
API Access

Turn Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=TTRX&period=max&api_key=YOUR_API_KEY